Pharmholding Binnopharm Group registered a representative office in Kazakhstan and will open offices in five more CIS countries by the end of 2021: Belarus, Azerbaijan, Moldavia, Armenia and Uzbekistan. It is expected to double export revenues to ₽4 billion in 2024, and prepare the infrastructure for entering the markets of the Middle East and Southeast Asia. Now Binnopharm Group supplies its products to 14 countries. The share of export sales is about 10% of the holding's revenue.